Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-25
DOI
10.1038/s41386-019-0577-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis
- (2019) Robert A. McCutcheon et al. MOLECULAR PSYCHIATRY
- Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
- (2018) Sameer Jauhar et al. MOLECULAR PSYCHIATRY
- Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years
- (2018) Jentien M Vermeulen et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
- (2017) A. Demjaha et al. PSYCHOLOGICAL MEDICINE
- Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia
- (2017) Stefan P. Brugger et al. JAMA Psychiatry
- Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment
- (2016) Deepak K. Sarpal et al. AMERICAN JOURNAL OF PSYCHIATRY
- Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
- (2016) Dan Siskind et al. BRITISH JOURNAL OF PSYCHIATRY
- Clozapine and Risperidone in Moderately Refractory Schizophrenia
- (2016) Nina R. Schooler et al. JOURNAL OF CLINICAL PSYCHIATRY
- Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
- (2016) J. Lally et al. PSYCHOLOGICAL MEDICINE
- Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia
- (2016) Myrto T. Samara et al. JAMA Psychiatry
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Meta-analysis of variation: ecological and evolutionary applications and beyond
- (2014) Shinichi Nakagawa et al. Methods in Ecology and Evolution
- Clozapine, a Fast-Off-D2 Antipsychotic
- (2013) Philip Seeman ACS Chemical Neuroscience
- Equipercentile linking of the BPRS and the PANSS
- (2013) S. Leucht et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The social and economic burden of treatment-resistant schizophrenia
- (2013) James L. Kennedy et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Geographic and Clinical Variation in Clozapine Use in the United States
- (2013) T. Scott Stroup et al. PSYCHIATRIC SERVICES
- Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
- (2012) Oliver D. Howes et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial
- (2011) Ali Ghaleiha et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- An Algorithm-Based Approach to First-Episode Schizophrenia
- (2011) Ofer Agid et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs
- (2009) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia
- (2009) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL PSYCHIATRY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
- (2009) Emilio Sacchetti et al. SCHIZOPHRENIA RESEARCH
- Fluctuation scaling in complex systems: Taylor's law and beyond1
- (2008) Zoltán Eisler et al. ADVANCES IN PHYSICS
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Clozapine and “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: A 12-Week Randomized and Double-Blind Comparison
- (2007) Sanjiv Kumra et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started